Suggest - Legal

The 109th Congress took as one of its favorite causes the issue of tort reform, passing legislation that severely limited an injured party’s ri

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ght to sue and collect damages, and there is an ongoing debate on further restrictions on the ability of people to sue. One thing that is broug

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ht up repeatedly is medical malpractice insurance. The rates have skyrocketed, and the Bush administration and former Republican majority in Co

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ngress have blamed lawsuits for the rise.

Lawsuits do have an impact on medical malpractice insurance rates. But what Bush and his Republican

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

friends don’t mention is that lawsuits have had only a relatively small effect on the cost of insurance. For the real blame, one has to look el

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

sewhere.

Insurance companies rake in billions of dollars a year from their customers, and then take the money and invest it. When the Enron de

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

bacle and other financial scandals hit Wall Street beginning in 2001, insurance companies were invested heavily in the stock market; and when t

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

he stock market took a dive, the insurance companies took a bath. Up went insurance rates on just about everything.

I do believe that lawsuits

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

can get out of hand, and that exorbitant damages are sometimes awarded. But rather than restricting access to the courts or putting a mandator

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

y cap on damages, why not take a deeper look?

Some people are motivated to sue simply for monetary gain, but, particularly with ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

w" href="http://www.bfslaw.com/practice-areas/personal-injury.html">medical malpractice cases, others want justice, and to blow the whistle

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

on incompetent or careless physicians. Too often a monetary settlement will occur and then the doctor will go right back to practicing medicin

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

e, with no consequences, and with the details of the case buried beneath a nondisclosure agreement.

I’m convinced that many injured parties wo

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

uld be more likely to accept reasonable settlements if they knew that action would be taken against an incompetent physician. Why not tie tort

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

reform, particularly as regards medical malpractice, to an investigation that takes a good hard governmental look at the care and competency of

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

the physicians and other practitioners involved? Why not outlaw nondisclosure agreements when it involves some kind of personal injury? After

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

all, the public’s right to know is surely important on the issue of medical malpractice.

The Congress should also look at the possibility of b

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

anning unnecessary delaying tactics used to wear down plaintiffs. These tactics often drag out a lawsuit for years and serve to cause the plain

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tiffs to give up. If the possibility of sanctions and stiff fines went along with this practice, it might end.

Alternative ways for plaintiffs

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

in malpractice cases to seek justice and receive equitable settlements might cut down considerably on both the frequency and cost of lawsuits.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.suggest.org.ua/article/127150/suggest-A-Different-Approach-Needed-for-Malpractice-Reform.html">A Different Approach Needed for Malpractice Reform</a>

BB link (for phorums):
[url=http://www.suggest.org.ua/article/127150/suggest-A-Different-Approach-Needed-for-Malpractice-Reform.html]A Different Approach Needed for Malpractice Reform[/url]

In using our communication skills and abilities how we say something is just as important as what we say. Body language plays an extremely important part of our communication. In fact studies have been done showing that when we interact in a communication process the receiver actually receives 7% of the message verbally. The other 93% is received based on the non-verbal aspects of the message.

In the financial arena, many terms are used to explain what amounts to be the same thing. Mortgages are home loans and equity is the cash value in your home. One term that is used that sometimes causes confusion is second mortgages.

If you are considering a whole insurance policy, it is easy to get an insurance broker to help you. Whole life insurance plans are among the major products of life insurance companies despite their weakening appeal to younger people. Young professionals would rather invest money on short-term insurance policies with high returns in a relatively short time. Thinking about 50 years from now is not especially appealing to most young people. But parents who think about the next generation who would benefit from the cash dividend and premium may look at whole life insurance as a long-term investment.

Tags

Links

Suggest - A Different Approach Needed for Malpractice Reform

Related Articles: